Channel Therapeutics Statistics
Total Valuation
CHRO has a market cap or net worth of $10.13 million. The enterprise value is $11.16 million.
Important Dates
The next estimated earnings date is Tuesday, March 4, 2025, before market open.
| Earnings Date | Mar 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CHRO has 6.03 million shares outstanding. The number of shares has increased by 333.40% in one year.
| Current Share Class | 6.03M |
| Shares Outstanding | 6.03M |
| Shares Change (YoY) | +333.40% |
| Shares Change (QoQ) | +0.32% |
| Owned by Insiders (%) | 20.34% |
| Owned by Institutions (%) | 1.35% |
| Float | 1.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | -7.09 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.60
| Current Ratio | 0.60 |
| Quick Ratio | 0.35 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.48 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -556.33% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 674.27% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.26M |
| Employee Count | 8 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -65.00% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -65.00% |
| 50-Day Moving Average | 1.33 |
| 200-Day Moving Average | 1.10 |
| Relative Strength Index (RSI) | 50.49 |
| Average Volume (20 Days) | 104,898 |
Short Selling Information
The latest short interest is 103,120, so 1.71% of the outstanding shares have been sold short.
| Short Interest | 103,120 |
| Short Previous Month | 1,207 |
| Short % of Shares Out | 1.71% |
| Short % of Float | 10.18% |
| Short Ratio (days to cover) | 0.04 |
Income Statement
| Revenue | n/a |
| Gross Profit | -3.19M |
| Operating Income | -9.63M |
| Pretax Income | -8.98M |
| Net Income | -10.07M |
| EBITDA | n/a |
| EBIT | -9.63M |
| Earnings Per Share (EPS) | -$2.20 |
Full Income StatementBalance Sheet
The company has $1.25 million in cash and $2.29 million in debt, giving a net cash position of -$1.03 million or -$0.17 per share.
| Cash & Cash Equivalents | 1.25M |
| Total Debt | 2.29M |
| Net Cash | -1.03M |
| Net Cash Per Share | -$0.17 |
| Equity (Book Value) | -1.43M |
| Book Value Per Share | -0.25 |
| Working Capital | -1.43M |
Full Balance SheetCash Flow
| Operating Cash Flow | -5.48M |
| Capital Expenditures | n/a |
| Free Cash Flow | -5.48M |
| FCF Per Share | -$0.91 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |